India Human Embryonic Stem Cells Market Size & Outlook
India human embryonic stem cells market, 2018-2030 (US$M)
Related Markets
India human embryonic stem cells market highlights
- The India human embryonic stem cells market generated a revenue of USD 26.0 million in 2023 and is expected to reach USD 71.6 million by 2030.
- The India market is expected to grow at a CAGR of 15.6% from 2024 to 2030.
- In terms of segment, regenerative medicine was the largest revenue generating application in 2023.
- Drug Discovery & Development is the most lucrative application segment registering the fastest growth during the forecast period.
Human embryonic stem cells market data book summary
| Market revenue in 2023 | USD 26.0 million |
| Market revenue in 2030 | USD 71.6 million |
| Growth rate | 15.6% (CAGR from 2023 to 2030) |
| Largest segment | Regenerative medicine |
| Fastest growing segment | Drug Discovery & Development |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Regenerative Medicine, Drug Discovery & Development |
| Key market players worldwide | Thermo Fisher Scientific Inc, Sartorius Stedim Biotech SA, Element Solutions Inc, PromoCell GmbH, Lonza Group Ltd, LifeCell International, Gilead Sciences Inc, International Stem Cell Corp |
Other key industry trends
- In terms of revenue, India accounted for 1.8% of the global human embryonic stem cells market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China human embryonic stem cells market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 233.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Human Embryonic Stem Cells Market Scope
Human Embryonic Stem Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
India human embryonic stem cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to human embryonic stem cells market will help companies and investors design strategic landscapes.
Regenerative medicine was the largest segment with a revenue share of 90.38% in 2023. Horizon Databook has segmented the India human embryonic stem cells market based on regenerative medicine, drug discovery & development covering the revenue growth of each sub-segment from 2018 to 2030.
- India Human Embryonic Stem Cells Application Outlook (Revenue, USD Million, 2018-2030)
- Regenerative Medicine
- Drug Discovery & Development
Reasons to subscribe to India human embryonic stem cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of India human embryonic stem cells market databook
-
Our clientele includes a mix of human embryonic stem cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India human embryonic stem cells market , including forecasts for subscribers. This country databook contains high-level insights into India human embryonic stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
India human embryonic stem cells market size, by application, 2018-2030 (US$M)
India Human Embryonic Stem Cells Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
